Prosecution Insights
Last updated: October 02, 2026

Examiner: MCINTOSH III, TRAVISS C

Tech Center 1600 • Art Units: 1623 1657 1673 1693

This examiner grants 73% of resolved cases

Analysis

Traviss C. McIntosh III is an examiner in Tech Center 1600 and Art Unit 1623. The examiner has 1334 resolved cases and an allowance rate of 73.2 percent. The median days to allowance is 885, which establishes a benchmark for the duration of the prosecution process. These statistics are derived from a large volume of work in this technical area.

The interview lift of 14.0 percent is an important metric for applicants. This figure shows the increase in the probability of allowance after an interview compared to the baseline allowance rate of 73.2 percent. A 14.0 percent lift suggests that verbal engagement is a productive strategy for resolving issues. The 885-day median to allowance provides a timeline for expectations when prosecuting cases before this examiner. With 1334 resolved cases, the data reflects a stable pattern of behavior. The 73.2 percent allowance rate indicates that a majority of applications reach a grant, and the 14.0 percent lift can further improve those odds.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

73.2%
Allow Rate
+13.2% vs TC avg
1,355
Total Applications
+14.0%
Interview Lift
885
Avg Prosecution Days
Based on 1334 resolved cases, 2023–2026

Rejection Statute Breakdown

6.1%
§101 Eligibility
23.4%
§102 Novelty
16.0%
§103 Obviousness
32.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18439034 STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE Non-Final OA UNIVERSITY OF MASSACHUSETTS
18675302 ENZYMATIC SYNTHESIS OF 4'-ETHYNYL NUCLEOSIDE ANALOGS Non-Final OA Merck Sharp & Dohme LLC
18704503 FINE CELLULOSE FIBER POWDER AND METHOD FOR PRODUCING FINE CELLULOSE FIBER POWDER Non-Final OA Yokogawa Electric Corporation
18835699 METHOD FOR PRODUCING OLIGONUCLEOTIDES Non-Final OA Nitto Denko Corporation
18258731 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME Final Rejection The Research Foundation for The State University of New York
18720093 A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS Non-Final OA Intervet Inc.
18022855 PROCESS FOR THE DIRECT CONVERSION OF CELLULOSE TO GLYCOLS USING NON-NOBLE METAL LOADED ZEOLITE CATALYSTS Non-Final OA COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month